nafoxidine has been researched along with Cystadenocarcinoma in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myers, AM | 1 |
| Moore, GE | 1 |
| Major, FJ | 1 |
1 other study available for nafoxidine and Cystadenocarcinoma
| Article | Year |
|---|---|
Advanced ovarian carcinoma: response to antiestrogen therapy.
Topics: Adult; Cystadenocarcinoma; Estrogen Antagonists; Female; Humans; Megestrol; Middle Aged; Nafoxidine; | 1981 |